Table 3.

Evaluation of disease activity of patients with AS in the 2 groups at different assessment times. Values are mean (SD) unless otherwise specified.

Variables	Intervention Group, n = 35				Control Group, n = 35				p Intergroup^**
Variables	T0	T6	T12	T24	T0	T6	T12	T24	p Intergroup^**
BASDAI	3.46 (2.39)	2.85 (2.20)^*	2.75 (2.12)^*	2.87 (1.97)	3.62 (2.06)	3.10 (2.00)^*	2.79 (1.99)^*	3.27 (2.07)	0.645
ASDAS, CRP	2.44 (1.07)	2.00 (0.95)^*	1.98 (0.93)^*	2.10 (0.92)	2.24 (0.91)	2.13 (0.88)^*	2.00 (0.94)^*	2.24 (0.89)	0.928
ASDAS, ESR	2.35 (0.93)	2.09 (0.89)^*	2.05 (0.92)^*	2.24 (0.95)	2.31 (0.83)	2.18 (0.82)^*	2.00 (0.87)^*	2.24 (0.84)	0.991
CRP, mg/l	10.49 (11.90)	7.04 (7.64)	7.14 (8.21)	6.53 (6.01)	6.01 (7.33)	5.50 (6.19)	4.95 (4.86)	7.84 (11.59)	0.290
ESR, mm/h	18.5 (12.5)	17.0 (10.0)	17.5 (12.8)	20.5 (15.2)	17.1 (13.6)	16.23 (13.7)	14.1 (12.5)	14.7 (9.7)	0.264

↵* p < 0.05 compared to T0.
↵** ANOVA test.
AS: ankylosing spondylitis; T0: baseline assessment before randomization; T6: assessment 6 weeks after the start of the program; T12: assessment 12 weeks after the start of the program; T24: assessment 24 weeks after the start of the program; BASDAI: Bath AS Disease Activity Index; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; ASDAS: AS Disease Activity Score.